Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

Roflumilast (Daxas) has been approved by the National Institute of Health and Care Excellence for the treatment of individuals with chronic obstructive pulmonary disease

Roflumilast (Daxas) has been approved by the National Institute of Health and Care Excellence to treat adults with severe chronic obstructive pulmonary disease whose symptoms continue to worsen despite other treatments

Source  Shutterstock.com